Actionable insights — The Tungsten Producer Poised to Benefit From the Squeeze
The repeatable analysis behind the pick: not that she bought Almonty, but how to isolate the single company that captures a critical-metal chokepoint — the integration test, the locked-offtake test, the insider/funding checks, and how to price a "becoming" stock against a dated catalyst. Written to rerun on the next strategic material.
How to read this page: each insight is a method — the screen that narrows a squeeze down to one name, the checks that confirm it, and what to watch when re-running it on another critical metal. The boxed line shows how it played out for Almonty (ALM). (Written newsletter — "read" links open the source post; no timestamps.)
1. Screen for the integrated mine-and-process producer outside the dominant supplier
The repeatable method
- Start from the bottleneck (processing, not mining) and require both steps in one company outside the dominant supplier: a miner that ships concentrate to China to be refined "has not detached from China's grip."
- Rank survivors by scale of integrated capacity — the producer whose own output can move the ex-China balance is the one that captures the scarcity rent.
- Reject pure miners and pure processors; the thesis only pays if the company controls the whole chain it sells from.
Here: Almonty is "the largest Western-aligned tungsten producer and the only major one that owns both mining and processing outside China" — Sangdong's Phase 2 alone (2027) is ~40% of non-Chinese global supply.
Watch for
- Whether a candidate processes its own concentrate or exports it; integrated capacity as a share of ex-China supply; whether peers are mine-only.
2. Require a locked offtake at a hard floor that matches the coming legal rule
The repeatable method
- Look for a binding offtake with a defined end-buyer and volume, ideally at a hard floor price (no cap) — that converts a commodity producer into a contracted-revenue one and de-risks the squeeze thesis.
- Check the offtake counterparty is on the right side of the dated legal forcing function (the sourcing ban), so the contract is the compliance solution buyers must lock in early.
- Treat "contractors locking in compliant supply now" as the demand pull that front-runs the rule's effective date.
Here: a May 2025 binding deal with Tungsten Parts Wyoming — ≥40 t/month of tungsten oxide for U.S. defense at a hard floor, no cap — fitting the Jan-1-2027 DFARS ban (China/Russia/Iran/N. Korea barred from the whole chain) "exactly."
Watch for
- Binding vs. non-binding offtakes; floor-price terms; whether the buyer is defense/government; the rule's effective date driving early lock-in.
3. Confirm insider alignment and a funded balance sheet before the build pays off
The repeatable method
- For a pre-cash-flow ramp story, verify management has skin in the game (large insider ownership, recent open-market buying) and relevant policy/operational pedigree on the board — alignment matters most when results are years out.
- Confirm the project is fully funded through its value-creating phase so the thesis doesn't depend on raising into a weak tape.
- Read the income statement past the headline: strip non-cash charges (warrant/derivative revaluations) to see whether operations are already profitable.
Here: CEO Lewis Black owns ~8M shares (>$130M), an active buyer in early 2025; board added Gen. Perna (Warp Speed logistics) and Alan Estevez (ex-Commerce export-control architect). ~$259.9M cash funds Sangdong Phase 2; the Q1 net loss was non-cash ($8.4M warrant revaluation) while EBITDA was +$6.1M.
Watch for
- Insider ownership and open-market buys; board members who shaped the relevant policy; cash vs. capex to completion; non-cash items masking operating profit.
4. Price a "becoming" stock against the dated catalyst — and set a buy-up-to discipline
The repeatable method
- Accept that a ramp name trades on what the asset becomes, not trailing revenue (here ~$4.6B cap on ~$100M revenue) — so anchor valuation to the Phase-2 output and the policy re-rating, not the current multiple.
- Use a discrete dated catalyst (a Section 232 report, an index inclusion) to time the thesis, and treat a sharp pullback ahead of it as the entry.
- Impose a buy-up-to ceiling so conviction doesn't turn into chasing — and size for the named risks (execution, dilution, single-commodity, price volatility).
Here: stock ~$16.46 after a ~30% pullback from its ~$23.50 April peak, with Section 232 (July 13), Russell 1000 inclusion (June 29) and Sangdong Phase 2 (2027) ahead — buy up to $22.
Watch for
- The catalyst date and outcome; index-inclusion passive demand; the convertible's conversion level (~$27.40) as a dilution marker; the buy-up-to ceiling vs. the current price.
Methods distilled from the Prinsights Pulse Premium post (text in transcript.txt) for personal study. Not investment advice. © Nomi Prins / Prinsights for source material.